Posts by Raymond J. March
Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Economics at San José State University. His research examines the public and private provision and governance of healthcare in the United States, particularly in pharmaceutical markets.
Let Competition, Not the FDA, Resolve the EpiPen Shortage


The only reliable remedy to mitigate shortages of any product is to allow competition in the market.

Government vs. Private Efforts to Promote Breastfeeding: My Response to a Critic


Private efforts to promote childhood nutrition (specifically breastfeeding) are superior to government “solutions.”

FDA Considers Regulating E-cigarette Juices


Despite the best of intentions, efforts to regulate vice frequently fail and can lead to harmful secondary effects for those they intend to help.

FDA Approves Medical App for Contraception


FDA behind the market in delivering contraceptive apps.

Open Up Off-Label Drug Communication and Let the Market Work!


Off-label information policy reform works to broaden what information drug providers can share.

Three Reasons To Be Optimistic about Pharmaceutical Policy


Right-to-try, MDMA, and Epidolex provide examples of the power of public opinion to change the scope of government.

If Telemedicine Is Underachieving, Government Is to Blame


Telemedicine providers have faced burdensome and complex regulatory structures at the state and federal level.

Putting Right-to-Try Drug Prices in Perspective


FDA regulation holds part of the blame for high drug prices.

EpiPen Pricing Controversy Reveals Ignorance about Market Competition


Increased competition is the remedy to skyrocketing drug prices.

Dear Congress, Please Don’t Keep Up with the Kardashians!


Kourtney Kardashian spoke on Capitol Hill in an attempt to motivate the federal government to play a larger role in regulating cosmetics. 

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org